LONG-TERM DRUG SURVIVAL OF ETANERCEPT VS OTHER TNF INHIBITOR THERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Emery, P. [1 ]
Vlahos, B. [2 ]
Szczypa, P. [3 ]
Thakur, M. [4 ]
Jones, H. E. [2 ]
Woolcott, J. [2 ]
Estrella, P. V. Santos [2 ]
Gibofsky, A. [5 ]
Rolland, C. [6 ]
Citera, G. [7 ]
Marshall, L. [2 ]
机构：
[1] Leeds Inst Rheumat & Musculoskeletal Med, Leeds Musculoskeletal Biomed Res Ctr LTHT, Leeds, W Yorkshire, England
[2] Pfizer, Collegeville, PA USA
[3] Pfizer Ltd, Walton Oaks, GA USA
[4] Pfizer, Sandwich, Kent, England
[5] Weill Med Coll, New York, NY USA
[6] Envis Pharma Grp, Horsham, W Sussex, England
[7] Consultorios Reumatol, Buenos Aires, DF, Argentina
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.2504
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0460
引用
收藏
页码：1391 / 1392
页数：3
相关论文
共 50 条
  • [1] Drug Survival and Long-Term Dose Comparison of Etanercept and Infliximab in Rheumatoid Arthritis Patients
    Hanna, Brian D.
    Shah, Alpesh
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S477 - S477
  • [2] Etanercept:: long-term clinical experience in rheumatoid arthritis and other arthritis
    Cobo-Ibanez, T.
    Martin-Mola, E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (09) : 1373 - 1397
  • [3] Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
    Neovius, M.
    Arkema, E. V.
    Olsson, H.
    Eriksson, J. K.
    Kristensen, L. E.
    Simard, J. F.
    Askling, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 354 - 360
  • [4] DETERMINATION OF ANTI-DRUG ANTIBODIES IN LONG-TERM TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS WITH ETANERCEPT
    Drynda, S.
    Beuermann, R.
    Kekow, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1033 - 1034
  • [5] Long Term Drug Survival of Adalimumab and Etanercept Treatment for Rheumatoid Arthritis with and without Methotrexate
    Visman, I. M.
    l'Ami, M. J.
    Wolbink, Gertjan
    Nurmohamed, Mike T.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] LONG-TERM SURVIVAL OF TUMOR NECROSIS FACTOR-ALPHA INHIBITOR THERAPIES IN A SPANISH COHORT OF RHEUMATOID ARTHRITIS PATIENTS
    Caliz, R.
    Ferrer, M. A.
    Soto, M. J.
    Garcia, A.
    Utrilla, A.
    Salas, P.
    Lopez-Sidro, M.
    Romani, L.
    Acevedo, Z.
    Notario, I
    Sainz, J.
    Caliz, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 434 - 434
  • [7] Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice
    Leon, L.
    Rodriguez-Rodriguez, L.
    Rosales, Z.
    Gomez, A.
    Lamas, J. R.
    Pato, E.
    Jover, J. A.
    Abasolo, L.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 (06) : 456 - 460
  • [8] Long-Term Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis in Clinical Practice
    Lurati, Alfredomaria
    Bertani, Luca
    Re, Katia Angela
    Marrazza, Mariagrazia
    Bompane, Daniela
    Scarpellini, Magda
    CLINICAL DRUG INVESTIGATION, 2013, 33 : S125 - S128
  • [9] Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study
    Markatseli, T. E.
    Alamanos, Y.
    Saougou, I.
    Voulgari, P. V.
    Drosos, A. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (01) : 31 - 38
  • [10] Long-term use of etanercept in patients with DMARD-refractory rheumatoid arthritis.
    Moreland, LM
    Cohen, SB
    Baumgartner, S
    Schiff, M
    Tindall, EA
    Burge, DJ
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S401 - S401
12345